Change in lifestyle behaviors and medication use after a diagnosis of ductal carcinoma in situ

Breast Cancer Research and Treatment

Volumn 124, Issue 2, 2010, Pages 487-495

  Sprague, Brian L ^a,b   Trentham Dietz, Amy ^a,b   Nichols, Hazel B ^b   Hampton, John M ^b   Newcomb, Polly A ^b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Breast neoplasms; Cohort study; Ductal carcinoma in situ; Epidemiology; Health behaviors

Indexed keywords

ANTIDEPRESSANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TAMOXIFEN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ATTITUDE TO ILLNESS; CANCER CHEMOTHERAPY; CANCER REGISTRY; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; FOOD INTAKE; HORMONAL THERAPY; HUMAN; INTERVIEW; INTRADUCTAL CARCINOMA; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; SMOKING;

ADULT; AGED; ALCOHOL DRINKING; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIDEPRESSIVE AGENTS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COHORT STUDIES; DIET; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ODDS RATIO; QUALITY OF LIFE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING CESSATION; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME; WEIGHT GAIN; WISCONSIN; YOUNG ADULT;

EID: 78649323640     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0869-0     Document Type: Article

References (45)

1. Silverstein MJ, Baril NB (2002) In situ carcinoma of the breast. In: Donegan WL, Spratt JS (eds) Cancer of the breast, 5th edn. Saunders, Philadelphia
2. Sprague BL, Trentham-Dietz A (2010) In situ breast cancer. In: Li CI (ed) Breast cancer epidemiology. Springer, New York, pp 47-72
3. BL Sprague A Trentham-Dietz 2009 Prevalence of breast carcinoma in situ in the United States JAMA 302 8 846 848 1:CAS:528:DC%2BD1MXhtVCnt7zK 10.1001/jama.2009.1211 19706857
4. HJ Burstein K Polyak JS Wong SC Lester CM Kaelin 2004 Ductal carcinoma in situ of the breast N Engl J Med 350 14 1430 1441 1:CAS:528:DC%2BD2cXivVagtrg%3D 10.1056/NEJMra031301 15070793 (Pubitemid 38419997)
5. E Rakovitch E Franssen J Kim, et al. 2003 A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer Breast Cancer Res Treat 77 3 285 293 10.1023/A: 1021853302033 12602928 (Pubitemid 36197643)
6. VL Ernster J Barclay K Kerlikowske H Wilkie R Ballard-Barbash 2000 Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program Arch Intern Med 160 7 953 958 1:STN:280:DC%2BD3c3it1GqtQ%3D%3D 10.1001/archinte.160.7.953 10761960
7. F Warnberg J Yuen L Holmberg 2000 Risk of subsequent invasive breast cancer after breast carcinoma in situ Lancet 355 9205 724 725 1:STN:280:DC%2BD3c7ms1Gnuw%3D%3D 10.1016/S0140-6736(99)03703-4 10703809
8. J Boyages G Delaney R Taylor 1999 Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis Cancer 85 3 616 628 1:STN:280:DyaK1M7ptVWmtA%3D%3D 10.1002/(SICI)1097-0142(19990201)85:3<616:: AID-CNCR12>3.0.CO;2-7 10091735 (Pubitemid 29075283)
9. K Kerlikowske A Molinaro I Cha, et al. 2003 Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy J Natl Cancer Inst 95 22 1692 1702 14625260
10. CI Li KE Malone BS Saltzman JR Daling 2006 Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001 Cancer 106 10 2104 2112 10.1002/cncr.21864 16604564 (Pubitemid 43673230)
11. LA Habel JR Daling PA Newcomb, et al. 1998 Risk of recurrence after ductal carcinoma in situ of the breast Cancer Epidemiol Biomarkers Prev 7 8 689 696 1:STN:280:DyaK1czot1entQ%3D%3D 9718221
12. SA Norman SL Potashnik ML Galantino, et al. 2007 Modifiable risk factors for breast cancer recurrence: what can we tell survivors? J Womens Health (Larchmt) 16 2 177 190 10.1089/jwh.2006.0047 (Pubitemid 46536927)
13. YR van Gestel AC Voogd AJ Vingerhoets, et al. 2007 A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ Eur J Cancer 43 3 549 556 10.1016/j.ejca.2006.10.010 17140788 (Pubitemid 46188524)
14. A Partridge K Adloff E Blood, et al. 2008 Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study J Natl Cancer Inst 100 4 243 251 10.1093/jnci/djn010 18270338 (Pubitemid 351480537)
15. HB Nichols A Trentham-Dietz KM Egan, et al. 2007 Oral contraceptive use and risk of breast carcinoma in situ Cancer Epidemiol Biomarkers Prev 16 11 2262 2268 1:CAS:528:DC%2BD2sXhtlSmur3K 10.1158/1055-9965.EPI-07-0456 18006914 (Pubitemid 351196358)
16. A Trentham-Dietz HB Nichols KM Egan, et al. 2007 Cigarette smoking and risk of breast carcinoma in situ Epidemiology 18 5 629 638 10.1097/EDE. 0b013e318127183a 17700252 (Pubitemid 47263040)
17. Fritz A, Percy C, Jack A et al (eds) (2000) International classification of diseases for oncology, 3rd edn. World Health Organization, Geneva
18. Armstrong BK, White E, Saracci R (1992) Principles of exposure measurement in epidemiology, vol 21. Oxford University Press, Oxford
19. BL Sprague A Trentham-Dietz PA Newcomb, et al. 2007 Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer Cancer Epidemiol Biomarkers Prev 16 2 236 243 10.1158/1055-9965.EPI-06- 0713 17301255 (Pubitemid 46383340)
20. PA Newcomb L Titus-Ernstoff KM Egan, et al. 2002 Postmenopausal estrogen and progestin use in relation to breast cancer risk Cancer Epidemiol Biomarkers Prev 11 7 593 600 1:CAS:528:DC%2BD38Xmt1Wks7g%3D 12101105 (Pubitemid 34760816)
21. Palta M (2003) Quantitative methods in population health; extensions of ordinary regression. Wiley, Hoboken
22. JE Rossouw GL Anderson RL Prentice, et al. 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 3 321 333 1:CAS:528:DC%2BD38Xltlegs7k%3D 10.1001/jama.288.3.321 12117397
23. ML Irwin A McTiernan RN Baumgartner, et al. 2005 Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors J Clin Oncol 23 4 774 782 10.1200/JCO.2005.04.036 15681521 (Pubitemid 46224176)
24. B Caan B Sternfeld E Gunderson, et al. 2005 Life after cancer epidemiology (LACE) study: a cohort of early stage breast cancer survivors (United States) Cancer Causes Control 16 5 545 556 10.1007/s10552-004-8340-3 15986109 (Pubitemid 40933624)
25. N Saquib SW Flatt L Natarajan, et al. 2007 Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the women's healthy eating and living (WHEL) study Breast Cancer Res Treat 105 2 177 186 10.1007/s10549-006-9442-2 17123151 (Pubitemid 47366880)
26. PJ Hoskin S Ashley JR Yarnold 1992 Weight gain after primary surgery for breast cancer-effect of tamoxifen Breast Cancer Res Treat 22 2 129 132 1:STN:280:DyaK3s%2FgsVyjsw%3D%3D 10.1007/BF01833342 1391977
27. JN Ingle DI Twito DJ Schaid, et al. 1991 Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis Cancer 67 4 886 891 1:STN:280:DyaK3M7itFekug%3D%3D 10.1002/1097-0142(19910215)67:4<886::AID- CNCR2820670405>3.0.CO;2-O 1991261
28. B Fisher J Costantino C Redmond, et al. 1989 A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors N Engl J Med 320 8 479 484 1:STN:280:DyaL1M7islChsw%3D%3D 10.1056/NEJM198902233200802 2644532 (Pubitemid 19062522)
29. AB Grey JP Stapleton MC Evans IR Reid 1995 The effect of the anti-estrogen tamoxifen on cardiovascular risk factors in normal postmenopausal women J Clin Endocrinol Metab 80 11 3191 3195 1:CAS:528:DyaK2MXptleitbo%3D 10.1210/jc.80.11.3191 7593425
30. Demark-Wahnefried W, Rimer BK, Winer EP (1997) Weight gain in women diagnosed with breast cancer. J Am Diet Assoc 97(5):519-526, 529; quiz 527-518
31. ML Irwin D Crumley A McTiernan, et al. 2003 Physical activity levels before and after a diagnosis of breast carcinoma: the health, eating, activity, and lifestyle (HEAL) study Cancer 97 7 1746 1757 10.1002/cncr.11227 12655532 (Pubitemid 36350718)
32. RE Patterson ML Neuhouser MM Hedderson, et al. 2003 Changes in diet, physical activity, and supplement use among adults diagnosed with cancer J Am Diet Assoc 103 3 323 328 12616253
33. JA Ligibel A Partridge A Giobbie-Hurder, et al. 2009 Physical activity behaviors in women with newly diagnosed ductal carcinoma-in situ Ann Surg Oncol 16 1 106 112 10.1245/s10434-008-0174-x 18953612
34. CA Thomson SW Flatt CL Rock, et al. 2002 Increased fruit, vegetable and fiber intake and lower fat intake reported among women previously treated for invasive breast cancer J Am Diet Assoc 102 6 801 808 10.1016/S0002-8223(02) 90180-X 12067045 (Pubitemid 40434184)
35. E Maunsell M Drolet J Brisson J Robert L Deschenes 2002 Dietary change after breast cancer: extent, predictors, and relation with psychological distress J Clin Oncol 20 4 1017 1025 10.1200/JCO.20.4.1017 11844825 (Pubitemid 34141846)
36. SJ Wayne ST Lopez LM Butler, et al. 2004 Changes in dietary intake after diagnosis of breast cancer J Am Diet Assoc 104 10 1561 1568 10.1016/j.jada.2004. 07.028 15389414 (Pubitemid 39278117)
37. MD Holmes S Murin WY Chen, et al. 2007 Smoking and survival after breast cancer diagnosis Int J Cancer 120 12 2672 2677 1:CAS:528:DC%2BD2sXkslGiurk%3D 10.1002/ijc.22575 17278091 (Pubitemid 46651290)
38. AL Hersh ML Stefanick RS Stafford 2004 National use of postmenopausal hormone therapy: annual trends and response to recent evidence JAMA 291 1 47 53 1:CAS:528:DC%2BD2cXisV2htA%3D%3D 10.1001/jama.291.1.47 14709575 (Pubitemid 38040534)
39. ML Kwan LA Habel ML Slattery B Caan 2007 NSAIDs and breast cancer recurrence in a prospective cohort study Cancer Causes Control 18 6 613 620 10.1007/s10552-007-9003-y 17404892 (Pubitemid 46883678)
40. K Meeske AW Smith CM Alfano, et al. 2007 Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL study report Qual Life Res 16 6 947 960 10.1007/s11136-007-9215-3 17457697 (Pubitemid 47174897)
41. J Chubak DS Buist DM Boudreau, et al. 2008 Breast cancer recurrence risk in relation to antidepressant use after diagnosis Breast Cancer Res Treat 112 1 123 132 1:CAS:528:DC%2BD1cXhtFOjtrnE 10.1007/s10549-007-9828-9 18058227
42. MJ Massie 2004 Prevalence of depression in patients with cancer J Natl Cancer Inst Monogr 32 57 71 10.1093/jncimonographs/lgh014 15263042
43. CH Kroenke WY Chen B Rosner MD Holmes 2005 Weight, weight gain, and survival after breast cancer diagnosis J Clin Oncol 23 7 1370 1378 10.1200/JCO.2005.01.079 15684320
44. L Holmberg H Anderson 2004 HABITS (hormonal replacement therapy after breast cancer-is it safe?), a randomised comparison: trial stopped Lancet 363 9407 453 455 1:STN:280:DC%2BD2c%2FnsVWgtw%3D%3D 10.1016/S0140-6736(04)15493-7 14962527 (Pubitemid 38210063)
45. CL Loprinzi SL Wolf DL Barton NN Laack 2008 Symptom management in premenopausal patients with breast cancer Lancet Oncol 9 10 993 1001 10.1016/S1470-2045(08)70256-0 19071256